Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 25021-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 25021-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Rop02 0004 01)

Chemical structure of ropivacaine hydrochloride monohydrate, showing the molecular formula C17H26N2O·HCl·H2O and molecular weight 328.89.*

FDA Label Image

Rop02 0007 02

Ropivacaine HCl Injection, USP 0.2% (2 mg/mL) solution in a 100 mL bag is labeled for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured for Sagent Pharmaceuticals, the label also includes usage instructions, storage conditions, and formulation details with a barcode and lot/expiration placeholders.*

FDA Label Image

Rop02 0007 03

Label of Ropivacaine HCl Injection USP 0.5% (5 mg/mL) in a 100 mL bag by Sagent Pharmaceuticals. The label specifies 500 mg per 100 mL, for infiltration, nerve block, and epidural administration only, not for intravenous use. It includes storage instructions and highlights the product is sterile, preservative-free, PVC-free, and DEHP-free, made in Switzerland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.